A potential biomarker for survival for non-metastatic kidney cancer
A recent study published in the journal International Urology and [...]
Association of anxiety and depression with outcomes for kidney cancer patients undergoing nephrectomy
A recent retrospective study of 1990 adults who had a [...]
Kidney cancer surgery in older patients
The RESURGE project retrospectively analysed data from three published studies [...]
Is there a role for cytoreductive nephrectomy?
This discussion with Dr Paul Russo presents a case for [...]
The role of cytoreductive nephrectomy in metastatic kidney cancer
Around 12,500 new cases of renal cell carcinoma (RCC) are [...]
ASCO 2019: Analysis of CARMENA trial results using IMDC risk groups
The results from CARMENA, a randomised phase III clinical trial [...]
Surgery may not be the most appropriate frontline treatment for metastatic kidney cancer
Results of the phase 3 SURTIME trial comparing pretreatment with [...]
ESOU 2019: Adjuvant therapy after nephrectomy for high-risk renal cell carcinoma
The following presentations were given at the European Association of [...]
Pros and cons of lymph node dissection at the time of nephrectomy
The following two presentations were given at the Canadian Uro-oncology [...]
Deferred cytoreductive nephrectomy in kidney cancer fails to improve progression-free survival
Results from the phase 3 CARMENA study, published in the [...]
